BDKRB1 and parasitic infectious disease: Under the circumstances, it is unlikely that pharmacological targeting of B1R might interfere with the phagocytic uptake of T. cruzi by splenic macrophages and this may explain why R-954 failed to reduce blood parasitemia during acute infection.